Related Experiment Videos
Sex differences in infection and sepsis
1College of Nursing, University of Cincinnati, ML0038, Cincinnati, OH 45221-0038, USA. Theresa.Beery@UC.edu
Critical Care Nursing Clinics of North America
|February 25, 2003
Summary
Sex and gender significantly impact immune responses and disease outcomes. Understanding these differences, beyond hormone levels, is crucial for developing effective treatments for infections and autoimmune conditions.
Area of Science:
- Immunology
- Endocrinology
- Public Health
Background:
- Sex and gender influence immune function, affecting responses to infection, sepsis, and autoimmune diseases.
- Estrogen generally enhances immune function, potentially leading to autoimmunity, while testosterone can suppress it, worsening outcomes in trauma.
- Pre-pubertal immune differences suggest factors beyond sex hormones, like gender-based exposures and societal roles, may play a part.
Purpose of the Study:
- To explore sex and gender-based disparities in immune responses to infection and sepsis.
- To investigate the role of sex hormones (estrogen, testosterone) in modulating immune function and disease outcomes.
- To highlight the need for considering sex and gender in clinical risk assessment and treatment development.
Main Methods:
- Review of existing literature on sex differences in immune responses.
- Analysis of hormonal influences (estrogen, testosterone) on immunity and disease.
- Consideration of non-hormonal gender-based factors, including societal roles and exposures.
Main Results:
- Sex and gender differences are evident in infection and sepsis outcomes.
- Sex hormones differentially modulate immune function, impacting autoimmune disease and trauma recovery.
- Early-life immune variations suggest multifactorial influences beyond sex hormones.
Conclusions:
- Clinicians must integrate sex and gender considerations into risk assessment for infection, sepsis, and immune dysfunction.
- Sex hormone-based therapies are emerging but require further efficacy data.
- Future strategies leveraging sex and gender differences in immunity may enhance clinical decision-making and long-term health outcomes.